Shorter Sleep Duration and Poorer Sleep Quality Linked to Alzheimer’s Disease Biomarker
October 22, 2013
Source: JAMA Neurology
Please note that these findings do not demonstrate a causal link between poor sleep and Alzheimer's disease. The study was based on an investigation involving 70 adults, with an average age of 76, from the Baltimore Longitudinal Study of Aging. Further studies with objective sleep measures are needed to further examine whether poor sleep definitively contributes to or accelerates Alzheimer's disease.
Poor sleep quality may impact Alzheimer’s disease onset and progression. This is according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health who examined the association between sleep variables and a biomarker for Alzheimer’s disease in older adults. The researchers found that personal reports of shorter sleep duration and poorer sleep quality were associated with greater levels of beta-amyloid deposits in the brain, a hallmark of the disease. The results are featured online in the October issue of JAMA Neurology.
“Our study found that among older adults, reports of shorter sleep duration and poorer sleep quality were associated with higher levels of beta-amyloid measured by PET scans of the brain,” said Adam Spira, PhD, lead author of the study and an assistant professor with the Bloomberg School’s Department of Mental Health. “These results could have significant public health implications as Alzheimer’s disease is the most common cause of dementia, and approximately half of older adults have insomnia symptoms.”
Alzheimer’s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills. According to the National Institutes of Health, as many as 5.1 million Americans may have the disease, with first symptoms appearing after age 60. Previous studies have linked disturbed sleep to cognitive impairment in older people.
In a cross-sectional study of adults from the neuro-imaging sub-study of the Baltimore Longitudinal Study of Aging with an average age of 76, the researchers examined the association between self-reported sleep variables and beta-amyloid deposition. Study participants reported sleep that ranged from more than seven hours to no more than five hours. Beta-amyloid deposition was measured by the Pittsburgh compound B tracer and PET (positron emission tomography) scans of the brain. Reports of shorter sleep duration and lower sleep quality were both associated with greater beta-amyloid buildup.
“These findings are important in part because sleep disturbances can be treated in older people. To the degree that poor sleep promotes the development of Alzheimer’s disease, treatments for poor sleep or efforts to maintain healthy sleep patterns may help prevent or slow the progression of Alzheimer disease,” said Spira. He added that the findings cannot demonstrate a causal link between poor sleep and Alzheimer’s disease, and that longitudinal studies with objective sleep measures are needed to further examine whether poor sleep contributes to or accelerates Alzheimer’s disease.
Adapted from Johns Hopkins Bloomberg School of Public Health
View all news updates for Alzheimer's disease
Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.